Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

BACKGROUND: The prognosis for children with malignant glioma is poor. This study was designed to determine whether lomustine and temozolomide following radiotherapy and concurrent temozolomide improves event-free survival (EFS) compared with historical controls with anaplastic astrocytoma (AA) or gl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Jakacki, Regina I., Cohen, Kenneth J., Buxton, Allen, Krailo, Mark D., Burger, Peter C., Rosenblum, Marc K., Brat, Daniel J., Hamilton, Ronald L., Eckel, Sandrah P., Zhou, Tianni, Lavey, Robert S., Pollack, Ian F.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Clinical Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035517/
https://ncbi.nlm.nih.gov/pubmed/27006176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars